About Modern Synthesis
Modern Synthesis is a company based in London (United Kingdom) founded in 2019 by Ben Reeve and Jen Keane. Modern Synthesis has raised $9.6 million across 2 funding rounds from investors including ARTESIAN PARTNERS, Petri Bio and Parley for the Oceans. Modern Synthesis offers products and services including Nanocellulose and Microcraft. Modern Synthesis operates in a competitive market with competitors including Texon, Heartbeat, WIDDOP, First Editions and Premier Limpet, among others.
- Headquarter London, United Kingdom
- Founders Ben Reeve, Jen Keane
-
Sectors
RetailChemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Modern Synthesis Limited
- Date of Incorporation 04 Jul, 2019
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
$403.09 K (USD)19.31as on Mar 31, 2022
-
Net Profit
$26.11 K (USD)-14.87as on Mar 31, 2022
-
EBITDA
$31.2 K (USD)28.43as on Mar 31, 2022
-
Total Equity Funding
$9.6 M (USD)
in 2 rounds
-
Latest Funding Round
$5.5 M (USD), Seed
Feb 05, 2025
-
Investors
ARTESIAN PARTNERS
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Modern Synthesis
Modern Synthesis offers a comprehensive portfolio of products and services, including Nanocellulose and Microcraft.
Sustainable fiber from microbes replacing plastics in textiles
Redefines craft using nanomaterials for eco-friendly applications
People of Modern Synthesis
Unlock access to complete
Funding Insights of Modern Synthesis
Modern Synthesis has successfully raised a total of $9.6M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $5.5 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Modern Synthesis
Modern Synthesis has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include ARTESIAN PARTNERS, Petri Bio and Parley for the Oceans.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Extantia is focused on investing in climate technology pioneers.
|
Locked | Locked | Locked | |
|
Private equity firm investing in multiple sectors
|
Locked | Locked | Locked | |
|
Single family office focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Modern Synthesis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Modern Synthesis
Investment portfolio details for Modern Synthesis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Modern Synthesis
Detailed financials for Modern Synthesis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Modern Synthesis Comparisons
Peer comparison for Modern Synthesis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Modern Synthesis
Modern Synthesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Texon, Heartbeat, WIDDOP, First Editions and Premier Limpet, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Material solutions for footwear, accessories, and apparel are contract-manufactured.
|
|
| Locked | Locked | Locked |
Contract manufacturing of furniture and shop design products is provided.
|
|
| Locked | Locked | Locked |
Home decor products are manufactured on contract by Widdop.
|
|
| Locked | Locked | Locked |
Bottles are manufactured on a contract basis for various clients.
|
|
| Locked | Locked | Locked |
Contract manufacturer of consumer goods
|
Detailed competitors of Modern Synthesis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Modern Synthesis
Complete news archive for Modern Synthesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Modern Synthesis
Modern Synthesis was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Modern Synthesis is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Jen Keane is the current CEO of Modern Synthesis. They have also founded this company.
Modern Synthesis is a funded company, having raised a total of $9.6M across 2 funding rounds to date.
Annual revenue of Modern Synthesis is $403.09K as on Mar 31, 2022.
Modern Synthesis was founded in 2019 in London, United Kingdom, within the biotechnology sector. Microbes are engineered to convert agricultural sugars into nanocellulose, producing customizable materials that replace animal- and fossil-fuel-derived options. Biology, material science, engineering, and design are integrated in the process to create circular solutions. Collaborations with companies are pursued to tackle issues such as greenhouse gas emissions, waste, land use, plastic pollution, and animal welfare.
Modern Synthesis offers Nanocellulose and Microcraft.
Modern Synthesis has 13 investors. Key investors include ARTESIAN PARTNERS, Petri Bio, Parley for the Oceans, Extantia, and Collab Fund.